BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 3:14:00 PM | Browse: 985 | Download: 871
Publication Name World Journal of Obstetrics and Gynecology
Manuscript ID 6071
Country Greece
Received
2013-10-01 18:41
Peer-Review Started
2013-10-01 20:30
To Make the First Decision
2013-10-21 11:08
Return for Revision
2013-10-21 16:59
Revised
2013-11-14 01:15
Second Decision
2013-12-10 16:34
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-12-11 09:58
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2013-12-17 18:37
Typeset the Manuscript
2014-01-17 13:48
Publish the Manuscript Online
2014-02-17 08:51
ISSN 2218-6220 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology & Nephrology
Manuscript Type Review
Article Title Desmopressin for the treatment of female storage lower urinary tract symptoms
Manuscript Source Invited Manuscript
All Author List Konstantinos Giannitsas and Anastasios Athanasopoulos
Funding Agency and Grant Number
Corresponding Author Anastassios Athanasopoulos, Professor, Department of Urology, Urodynamic Urology Unit, Patras University Hospital, Patras University, Panepistimioupoli, 26500 Patras, Achaia, Greece. tassos_athan@hotmail.com
Key Words Lower urinary tract symptoms; Storage; Nocturia; Overactive bladder; Desmopressin; Female; Nocturnal polyuria
Core Tip Recent data suggest that desmopressin in its oral formulations offers significant improvements in nocturia as well as daytime storage symptoms in female patients. The treatment rationale for nocturia is that nocturnal polyuria due to inadequate antidiuresis is a major contributing factor to nocturia. In the case of daytime storage symptoms, desmopressin taken on demand can postpone their manifestation by delaying bladder filling. Desmopressin is well tolerated and the risk of hyponatremia is low with appropriate dosing, based on a lower minimum effective dose in females compared to males.
Publish Date 2014-02-17 08:51
Citation Giannitsas K, Athanasopoulos A. Desmopressin for the treatment of female storage lower urinary tract symptoms. World J Obstet Gynecol 2014; 3(1): 7-13
URL http://www.wjgnet.com/2218-6220/full/v3/i1/7.htm
DOI http://dx.doi.org/10.5317/wjog.v3.i1.7
Full Article (PDF) WJOG-3-7.pdf
Full Article (Word) WJOG-3-7.doc
Manuscript File 6071-Review.docx
Answering Reviewers 6071-Answering Reviewers.pdf
Copyright License Agreement 6071-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 6071-Language certificate.pdf
Peer-review Report 6071-Peer review(s).pdf
Scientific Editor Work List 6071-Scientific editor work list.doc